Zobrazeno 1 - 10
of 432
pro vyhledávání: ''
Autor:
J M Seager, Christopher J. Hawkey
Publikováno v:
BMJ. 323:1236-1239
Non-steroidal anti-inflammatory drugs (NSAIDs) are usually thought to pose a dilemma for doctors wishing to prescribe them. Their anti-inflammatory and analgesic properties have led to their widespread use for rheumatoid and (much more commonly) othe
Publikováno v:
Scopus-Elsevier
Objective: To assess the efficacy and safety of interferon alfa with or without ribavirin for treatment of chronic hepatitis C. Design: Systematic review of randomised trials on interferon alfa plus ribavirin combination therapy versus interferon alf
Publikováno v:
BMJ. 323:419-422
Treatment of Indian visceral leishmaniasis with single or daily infusions of low dose liposomal amphotericin B: randomised trial {#article-title-2} Objective: To test short course, low dose liposomal amphotericin B as single or daily infusion treatme
Publikováno v:
BMJ. 318:833-837
Objectives: To determine whether eradication of Helicobacter pylori relieves the symptoms of functional dyspepsia. Design: Multicentre randomised double blind placebo controlled trial. Subjects: 278 patients infected with H pylori who had functional
Autor:
K R W Gillon, S. Müller-Lissner, K D Bardhan, Claire Fulton, R A Peacock, M A Bigard, G. Bianchi Porro, D G Weir, Julio Ponce, Mairi G B Scott, J. Hosie
Publikováno v:
BMJ. 318:502-507
Objective: To assess intermittent treatment over 12 months in patients with symptomatic gastro-oesophageal reflux disease. Design: Randomised, multicentre, double blind, controlled study. Patients with heartburn and normal endoscopy results or mild e
Publikováno v:
BMJ. 316:1720-1723
Gastro-oesophageal reflux disease is caused by retrograde flow of gastric contents through an incompetent gastro-oesophageal junction. The disease encompasses a broad spectrum of clinical disorders from heartburn without oesophagitis to severe compli
Publikováno v:
BMJ. 316:1648-1654
Objective: To determine how small differences in the efficacy and cost of two antibiotic regimens to eradicate Helicobacter pylori can affect the overall cost effectiveness of H pylori eradication in duodenal ulcer disease. Design: A decision analysi
Autor:
T K Jha, P Olliaro, C P N Thakur, T P Kanyok, B L Singhania, I J Singh, N K P Singh, S Akhoury, S Jha, D. N J Lockwood
Publikováno v:
BMJ. 316:1200-1205
Objectives: To assess the efficacy and tolerability of aminosidine compared with sodium stibogluconate for treating visceral leishmaniasis. Design: Randomised, unblinded, controlled trial with 180 day follow up. Setting: Kala-Azar Research Centre, Br
Autor:
Robert D. Goldin, Sally Hargreaves, Howard C. Thomas, Janice Main, Graham R. Foster, Iain M. Murray-Lyon
Publikováno v:
BMJ. 315:453-458
OBJECTIVE: To assess the attendance, outcome, compliance with treatment, and response to interferon alfa in patients with chronic hepatitis C who attended during 1995 and were treated according to a biopsy based algorithm. DESIGN: Retrospective audit
Autor:
V Sainio, Eero Kivilaakso, Ulf-Håkan Stenman, Jari Leinonen, Reijo Haapiainen, Tom Schröder, Esko Kemppainen, J Hedström
Publikováno v:
BMJ. 313:333-337
Objective: To estimate the usefulness of serum concentrations of the complex of trypsin 2 and (alpha)1 antitrypsin in diagnosing and assessing the severity of acute pancreatitis in comparison with serum C reactive protein, amylase, and trypsinogen 2